Barr and Par settle patent challenge with Valeant
Under the terms of the settlement, Barr will have the right to launch generic versions of diastat and diastat AcuDial on or after September 1, 2010, or earlier
Mediar Therapeutics has announced a collaboration and option agreement with Ono Pharmaceutical to develop new treatments for fibro-inflammatory diseases.